1. Home
  2. Programs
  3. FDA Drug Information Updates
advertisement

Drug Name Review

ReachMD Healthcare Image
Restart
Resume
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details
  • Overview

    Before any drug reaches the market, its name is thoroughly examined to identify misleading or potentially confusing names. FDA Drug Info Rounds pharmacists discuss FDA's responsibility for reviewing and approving new product names. The screening process for proposed proprietary drug names is reviewed, and the role of the Division of Medication Error Prevention and Analysis (DMEPA) and Office of Prescription Drug Promotion (OPDP) are explained.

    Learn more about the FDA Drug Info Rounds...

Recommended
Details
  • Overview

    Before any drug reaches the market, its name is thoroughly examined to identify misleading or potentially confusing names. FDA Drug Info Rounds pharmacists discuss FDA's responsibility for reviewing and approving new product names. The screening process for proposed proprietary drug names is reviewed, and the role of the Division of Medication Error Prevention and Analysis (DMEPA) and Office of Prescription Drug Promotion (OPDP) are explained.

    Learn more about the FDA Drug Info Rounds...

Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free